{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:35:00Z","timestamp":1761597300761},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,9,8]],"date-time":"2011-09-08T00:00:00Z","timestamp":1315440000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s10620-011-1880-y","type":"journal-article","created":{"date-parts":[[2011,9,7]],"date-time":"2011-09-07T12:03:21Z","timestamp":1315397001000},"page":"320-326","source":"Crossref","is-referenced-by-count":10,"title":["Prevention of Induced Colitis in Mice by the Ras Antagonist Farnesylthiosalicylic Acid"],"prefix":"10.1007","volume":"57","author":[{"given":"Tal","family":"Oron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galit","family":"Elad-Sfadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roni","family":"Haklai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeta","family":"Aizman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Brazowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoel","family":"Kloog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimon","family":"Reif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,8]]},"reference":[{"key":"1880_CR1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","volume":"347","author":"DK Podolsky","year":"2002","unstructured":"Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417\u2013429.","journal-title":"N Engl J Med"},{"key":"1880_CR2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/gast.2001.22122","volume":"120","author":"F Shanahn","year":"2001","unstructured":"Shanahn F. Inflammatory bowel disease: Immunodiagnostics, immunotheraputics, and ecotherapeutics. Gastroenterology. 2001;120:622\u2013635.","journal-title":"Gastroenterology"},{"key":"1880_CR3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0016-5085(98)70381-6","volume":"115","author":"C Fiocchi","year":"1998","unstructured":"Fiocchi C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology. 1998;115:182\u2013205.","journal-title":"Gastroenterology"},{"key":"1880_CR4","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1096\/fasebj.7.9.8330683","volume":"7","author":"GM Bokoch","year":"1993","unstructured":"Bokoch GM, Der CJ. Emerging concepts in the Ras superfamily of GTP-binding proteins. FASEB J. 1993;7:750\u2013759.","journal-title":"FASEB J"},{"key":"1880_CR5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0955-0674(99)00071-X","volume":"12","author":"GW Reuther","year":"2000","unstructured":"Reuther GW, Der CJ. The Ras branch of small GTPases: Ras family members don\u2019t fall far from the tree. Curr Opin Cell Biol. 2000;12:157\u2013165.","journal-title":"Curr Opin Cell Biol"},{"key":"1880_CR6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1126\/science.277.5324.333","volume":"277","author":"K Scheffzek","year":"1997","unstructured":"Scheffzek K, Ahmadian MR, Kabsch W, et al. The Ras-RasGAP complex: Structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science. 1997;277:333\u2013338.","journal-title":"Science"},{"key":"1880_CR7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2005.07.008","volume":"168","author":"M Kafri","year":"2005","unstructured":"Kafri M, Kloog Y, Korczyn AD, et al. Inhibition of Ras attenuates the course of experimental autoimmune neuritis. J Neuroimmunol. 2005;168:46\u201355.","journal-title":"J Neuroimmunol"},{"key":"1880_CR8","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/01.ASN.0000057543.55318.8B","volume":"14","author":"HC Clarke","year":"2003","unstructured":"Clarke HC, Kocher HM, Khwaja A, et al. Ras antagonist farnesylthiosalicylic acid (FTS) reduces glomerular cellular proliferation and macrophage number in rat thy-1 nephritis. J Am Soc Nephrol. 2003;14:848\u2013854.","journal-title":"J Am Soc Nephrol"},{"key":"1880_CR9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1365-2249.2001.01674.x","volume":"126","author":"A Katzav","year":"2001","unstructured":"Katzav A, Kloog Y, Korczyn AD, et al. Treatment of MRL\/lpr mice, a genetic autoimmune model, with the Ras inhibitor FTS. Clin Exp Immunol. 2001;126:570\u2013577.","journal-title":"Clin Exp Immunol"},{"key":"1880_CR10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.leu.2401367","volume":"13","author":"S Weijzen","year":"1999","unstructured":"Weijzen S, Velders MP, Kast WM. Modulation of the immune response and tumor growth by activated Ras. Leukemia. 1999;13:502\u2013513.","journal-title":"Leukemia"},{"key":"1880_CR11","doi-asserted-by":"crossref","unstructured":"Haklai R, Weisz MG, Elad G, et al. Dislodgment and accelerated degradation of Ras. Biochemistry. 1998;37:1306\u20131314.","DOI":"10.1021\/bi972032d"},{"key":"1880_CR12","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1074\/jbc.270.38.22263","volume":"270","author":"M Marom","year":"1995","unstructured":"Marom M, Haklai R, Ben-Baruch G, et al. Selective inhibition of Ras-dependent cell growth by farnesylthiosalisylic acid. J Biol Chem. 1995;270:2263\u20132270.","journal-title":"J Biol Chem"},{"key":"1880_CR13","doi-asserted-by":"crossref","first-page":"37169","DOI":"10.1074\/jbc.M205698200","volume":"277","author":"G Elad-Sfadia","year":"2002","unstructured":"Elad-Sfadia G, Haklai R, Ballan E, et al. Galectin-1 augments Ras activation and diverts Ras signals to Raf-1 at the expense of phosphoinositide 3-kinase. J Biol Chem. 2002;277:37169\u201337175.","journal-title":"J Biol Chem"},{"key":"1880_CR14","doi-asserted-by":"crossref","first-page":"34822","DOI":"10.1074\/jbc.M312697200","volume":"279","author":"G Elad-Sfadia","year":"2004","unstructured":"Elad-Sfadia G, Haklai R, Balan E, et al. Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase. J Biol Chem. 2004;279:34822\u201334930.","journal-title":"J Biol Chem"},{"key":"1880_CR15","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1091\/mbc.E07-10-1053","volume":"19","author":"L Belanis","year":"2008","unstructured":"Belanis L, Sarah J, Plowman SJ, et al. Galectin-1 is a novel structural component and a major regulator of H-Ras nanoclusters. Mol Biol Cell. 2008;19:1404\u20131414.","journal-title":"Mol Biol Cell"},{"key":"1880_CR16","doi-asserted-by":"crossref","unstructured":"Shalom-Feuerstein R, Levy R, Makovski V, et al. Galectin-3 regulates RasGRP4-mediated activation of N-Ras and H-Ras. Biochim Biophys Acta. 2008;1783:985\u2013993.","DOI":"10.1016\/j.bbamcr.2008.03.009"},{"key":"1880_CR17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1357-4310(00)01789-5","volume":"6","author":"Y Kloog","year":"2000","unstructured":"Kloog Y, Cox AD. RAS inhibitors: potential for cancer therapeutics. Mol Med Today. 2000;6:398\u2013402.","journal-title":"Mol Med Today"},{"key":"1880_CR18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00062752-200207000-00008","volume":"9","author":"DT Le","year":"2002","unstructured":"Le DT, Shannon KM. Ras processing as a therapeutic target in hematologic malignancies. Curr Opin Hematol. 2002;9:308\u2013315.","journal-title":"Curr Opin Hematol"},{"key":"1880_CR19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jhep.2004.04.010","volume":"41","author":"S Reif","year":"2004","unstructured":"Reif S, Aeed H, Shilo Y, et al. Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid. J Hepatol. 2004;41:235\u2013241.","journal-title":"J Hepatol"},{"key":"1880_CR20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0168-8278(99)80318-3","volume":"31","author":"S Reif","year":"1999","unstructured":"Reif S, Weis B, Aeed H, et al. The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats. J Hepatol. 1999;31:1053\u20131061.","journal-title":"J Hepatol"},{"key":"1880_CR21","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1021\/jm00008a004","volume":"38","author":"D Marciano","year":"1995","unstructured":"Marciano D, Ben-Bar G, Marom M, et al. Farnesyl derivatives of rigid carboxylic acid-inhibitors of Ras dependent cell growth. J Med Chem. 1995;38:1267\u20131272.","journal-title":"J Med Chem"},{"key":"1880_CR22","first-page":"471","volume":"20","author":"A Paz","year":"2000","unstructured":"Paz A, Haklai R, Elad G, et al. Galectin-1 binds H-Ras to mediate Ras membrane anchorage and cell transformation. Oncogene. 2000;20:471\u2013474.","journal-title":"Oncogene"},{"key":"1880_CR23","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1053\/gast.2002.32994","volume":"122","author":"D Rachmilewitz","year":"2002","unstructured":"Rachmilewitz D, Karmeli F, Takabayashi K, et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology. 2002;122:1428\u20131441.","journal-title":"Gastroenterology"},{"key":"1880_CR24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/1523-1747.ep12506462","volume":"78","author":"PP Bradley","year":"1982","unstructured":"Bradley PP, Priebat DA, Christensen RD, et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206\u2013209.","journal-title":"J Invest Dermatol"},{"key":"1880_CR25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0016-5085(19)31672-5","volume":"75","author":"P Sharon","year":"1978","unstructured":"Sharon P, Ligumsky M, Rachmilewitz D, et al. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology. 1978;75:638\u2013640.","journal-title":"Gastroenterology"},{"key":"1880_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(01)00385-X","volume":"120","author":"D Karussis","year":"2000","unstructured":"Karussis D, Abramsky O, Grigoriadis N, et al. The Ras-pathway inhibitor S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis. J Neuroimmunol. 2000;120:1\u20139.","journal-title":"J Neuroimmunol"},{"key":"1880_CR27","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s10620-007-9984-0","volume":"53","author":"I Zvibel","year":"2008","unstructured":"Zvibel I, Bar-Zohar D, Kloog Y, et al. The effect of Ras inhibition on the proliferation, apoptosis and matrix metalloproteases activity in rat hepatic stellate cells. Dig Dis Sci. 2008;53:1048\u20131053.","journal-title":"Dig Dis Sci"},{"key":"1880_CR28","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1073\/pnas.0702975104","volume":"104","author":"JB Olivera","year":"2007","unstructured":"Olivera JB, Biedere N, Niemela JE, et al. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci USA. 2007;104:8953\u20138958.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1880_CR29","first-page":"307","volume":"134","author":"PE Fields","year":"2000","unstructured":"Fields PE, Gajewski TF. Biochemical analysis of activated T lymphocytes. Protein phosphorylation and Ras, ERK, and JNK activation. Methods Mol Biol. 2000;134:307\u2013317.","journal-title":"Methods Mol Biol"},{"key":"1880_CR30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0952-7915(00)00089-3","volume":"12","author":"E Genot","year":"2000","unstructured":"Genot E, Cantrell DA. Ras regulation and function in lymphocytes. Curr Opin Immunol. 2000;12:289\u2013294.","journal-title":"Curr Opin Immunol"},{"key":"1880_CR31","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/eji.200838292","volume":"38","author":"A Mor","year":"2008","unstructured":"Mor A, Keren G, Kloog Y, et al. N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells. Eur J Immunol. 2008;38:1493\u20131502.","journal-title":"Eur J Immunol"},{"key":"1880_CR32","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1182\/blood-2006-06-031088","volume":"110","author":"RE Marks","year":"2007","unstructured":"Marks RE, Ho AW, Robbel C, et al. Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level. Blood. 2007;110:1982\u20131988.","journal-title":"Blood"},{"key":"1880_CR33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejphar.2009.06.001","volume":"616","author":"A Mor","year":"2009","unstructured":"Mor A, Kloog Y, Keren G, et al. Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice. Eur J Pharmacol. 2009;616:301\u2013305.","journal-title":"Eur J Pharmacol"},{"key":"1880_CR34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1053\/j.gastro.2003.11.019","volume":"126","author":"D Rachmilewitz","year":"2004","unstructured":"Rachmilewitz D, Katakura K, Karmeli F, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology. 2004;126:520\u2013528.","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1880-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-011-1880-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1880-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T02:18:32Z","timestamp":1560565112000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-011-1880-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1880"],"URL":"https:\/\/doi.org\/10.1007\/s10620-011-1880-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,8]]}}}